Abeona Therapeutics Inc (NAS:ABEO)
$ 4.2 -0.25 (-5.62%) Market Cap: 171.56 Mil Enterprise Value: 124.74 Mil PE Ratio: 0 PB Ratio: 7.51 GF Score: 45/100

Q2 2019 Abeona Therapeutics Inc Earnings Call Transcript

Aug 12, 2019 / 02:00PM GMT
Release Date Price: $57 (-0.44%)
Operator

Good morning, ladies and gentlemen, and welcome to the Abeona Therapeutics Inc. Second Quarter 2019 Earnings and Business Update Conference Call. Today's call is being recorded. (Operator Instructions) For opening remarks and introductions, I'll turn the call over to the Sofia Warner, Senior Director, Investor Relations. Thank you. You may begin.

Sofia Warner
Abeona Therapeutics Inc. - Senior Director of IR

Thank you. Good morning, and welcome, everyone. Today's call will be led by João Siffert, our Chief Executive Officer. Following João, Tim Miller, our President and Chief Scientific Officer, will present preclinical highlight; and Christine Silverstein, our Chief Financial Officer, will review our financials.

Before I turn the call over to them, I need to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in these statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot